Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure

Haegeun Song1,2, Jong-Hwa Ahn3, Min Gyu Kang4,5

  • 1Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea.

Insights

Acute myocardial infarction (AMI) patients show higher inflammation than non-AMI patients. Early high-sensitivity C-reactive protein (hs-CRP) predicts outcomes in AMI, while later hs-CRP predicts outcomes in both AMI and non-AMI patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation Research

Background:

  • High-sensitivity C-reactive protein (hs-CRP) is a marker for inflammation and cardiovascular disease risk.
  • Limited data exists on the temporal profile of hs-CRP and its association with outcomes based on disease acuity.

Purpose of the Study:

  • To investigate the temporal profile of hs-CRP in patients undergoing percutaneous coronary intervention (PCI).
  • To evaluate the relationship between hs-CRP levels and major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI) versus stable coronary artery disease.

Main Methods:

  • A cohort of 4,263 East Asian patients undergoing PCI for AMI or stable disease was studied.
  • hs-CRP levels were measured at baseline and 1 month post-PCI.
  • Patients were followed for up to 4 years for MACE (death, myocardial infarction, stroke) and major bleeding.

Main Results:

  • AMI patients exhibited higher baseline and 1-month post-PCI hs-CRP levels compared to non-AMI patients (p < 0.001).
  • Elevated baseline hs-CRP (≥ 2.4 mg/L) predicted higher MACE within 1 month only in the AMI group (aHR: 7.66).
  • Elevated 1-month hs-CRP (≥ 1.6 mg/L) predicted higher MACE between 1 month and 4 years in both AMI (aHR: 2.40) and non-AMI groups (aHR: 2.67).

Conclusions:

  • Patients with AMI experience heightened inflammation in both early and late post-PCI phases compared to non-AMI patients.
  • Baseline hs-CRP is a significant predictor of short-term outcomes exclusively in AMI patients.
  • The prognostic value of hs-CRP for long-term outcomes is comparable between AMI and non-AMI patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
32
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
17
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18